These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 23557459

  • 1. Assessment of long-term omalizumab treatment in patients with severe allergic asthma long-term omalizumab treatment in severe asthma.
    Özgür ES, Özge C, Ïlvan A, Naycı SA.
    J Asthma; 2013 Aug; 50(6):687-94. PubMed ID: 23557459
    [Abstract] [Full Text] [Related]

  • 2. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
    Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM, QUALITX Study Investigators.
    J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.
    Tzortzaki EG, Georgiou A, Kampas D, Lemessios M, Markatos M, Adamidi T, Samara K, Skoula G, Damianaki A, Schiza S, Tzanakis N, Siafakas NM.
    Pulm Pharmacol Ther; 2012 Feb; 25(1):77-82. PubMed ID: 22155001
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R, Chung KF, Panahloo Z, Blogg M, Ayre G.
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [Abstract] [Full Text] [Related]

  • 8. "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.
    Brusselle G, Michils A, Louis R, Dupont L, Van de Maele B, Delobbe A, Pilette C, Lee CS, Gurdain S, Vancayzeele S, Lecomte P, Hermans C, MacDonald K, Song M, Abraham I.
    Respir Med; 2009 Nov; 103(11):1633-42. PubMed ID: 19619998
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Omalizumab is effective in the long-term control of severe allergic asthma.
    Lanier BQ, Corren J, Lumry W, Liu J, Fowler-Taylor A, Gupta N.
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):154-9. PubMed ID: 12952109
    [Abstract] [Full Text] [Related]

  • 11. Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control.
    Molimard M, Mala L, Bourdeix I, Le Gros V.
    Respir Med; 2014 Apr; 108(4):571-6. PubMed ID: 24565601
    [Abstract] [Full Text] [Related]

  • 12. Changes of immunomodulatory cytokines associated with omalizumab therapy for severe persistent asthma.
    Shimizu Y, Dobashi K, Fueki N, Fueki M, Okada T, Tomioka S, Makino S, Mori M.
    J Biol Regul Homeost Agents; 2011 Apr; 25(2):177-86. PubMed ID: 21880206
    [Abstract] [Full Text] [Related]

  • 13. The real-life clinical effects of 52 weeks of omalizumab therapy for severe persistent allergic asthma.
    Gouder C, West LM, Montefort S.
    Int J Clin Pharm; 2015 Feb; 37(1):36-43. PubMed ID: 25394832
    [Abstract] [Full Text] [Related]

  • 14. [Omalizumab treatment in patients with asthma: summary of Meir Medical Center experience with 47 patients].
    Shitrit D, Talker O, Metabichek A, Yaakovi I.
    Harefuah; 2012 Apr; 151(4):216-9, 254, 253. PubMed ID: 22616149
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Add-on omalizumab improves day-to-day symptoms in inadequately controlled severe persistent allergic asthma.
    Humbert M, Berger W, Rapatz G, Turk F.
    Allergy; 2008 May; 63(5):592-6. PubMed ID: 18355388
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study.
    Maselli DJ, Singh H, Diaz J, Peters JI.
    Ann Allergy Asthma Immunol; 2013 Jun; 110(6):457-61. PubMed ID: 23706716
    [Abstract] [Full Text] [Related]

  • 19. Short and long-term quality of life and asthma control with omalizumab therapy in a real life setting in Portugal.
    Vieira T, de Oliveira JF, da Graça Castel-Branco M.
    Allergol Immunopathol (Madr); 2014 Jun; 42(1):3-10. PubMed ID: 23253691
    [Abstract] [Full Text] [Related]

  • 20. Association between consistent omalizumab treatment and asthma control.
    Lafeuille MH, Gravel J, Zhang J, Gorsh B, Figliomeni M, Lefebvre P.
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):51-7. PubMed ID: 24229822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.